0000950005-05-000295.txt : 20120615 0000950005-05-000295.hdr.sgml : 20120615 20050328160312 ACCESSION NUMBER: 0000950005-05-000295 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20050328 DATE AS OF CHANGE: 20050328 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VENTURE LENDING & LEASING IV INC CENTRAL INDEX KEY: 0001271808 IRS NUMBER: 200372373 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80610 FILM NUMBER: 05706755 BUSINESS ADDRESS: STREET 1: 2010 NORTH FIRST STREET STREET 2: SUITE 310 CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: 4084368577 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Pfizer Master Trust CENTRAL INDEX KEY: 0001320892 IRS NUMBER: 136064112 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 573-1133 MAIL ADDRESS: STREET 1: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G 1 p19235_13g.txt SC 13G ---------------------------- OMB APPROVAL Omb Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response .......11 ---------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ________)* Venture Lending & Leasing IV, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Shares -------------------------------------------------------------------------------- (Title of Class of Securities) NONE -------------------------------------------------------------------------------- (CUSIP Number) June 18, 2004 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 1 of 7 pages CUSIP No. NONE -------------------------------------------------------------------------------- 1. Names of Reporting Persons. Pfizer Master Trust I.R.S. Identification Nos. of above persons (entities only). -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) X -------------------------------------------------------------------------------- 3. SEC Use Only -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Illinois --------------------- ---------------------------------------------------------- Number of Shares Beneficially by 5. Sole Voting Power Owned by Each Reporting Person 10,000 (See Item 4). With: --------------------- ---------------------------------------------------------- 6. Shared Voting Power 0 --------------------- ---------------------------------------------------------- 7. Sole Dispositive Power 10,000 (See Item 4). --------------------- ---------------------------------------------------------- 8. Shared Dispositive Power 0 -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person. 10,000 (See Item 4) -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 10% (See Item 4) -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO -------------------------------------------------------------------------------- Pages 2 of 7 pages Item 1. (a) Name of Issuer: Venture Lending & Leasing IV, Inc. (b) Address of Issuer's Principal Executive Offices: 2010 North First Street, Suite 310, San Jose, California 95131 Item 2. (a) Name of Person Filing: Pfizer Master Trust (b) Address of Principal Business Office or, if none, Residence: c/o Benefit Financing, 235 East 42nd Street, 27th Floor, New York, New York 10017 (c) Citizenship: Illinois (d) Title of Class of Securities: Common Stock, $0.001 par value per share. (e) CUSIP Number: None. Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether person filing is a: (a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [_] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [_] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: As of the filing date of this Schedule 13G, the reporting person beneficially owns a 10% membership interest in Venture Lending & Leasing IV, LLC (the "Company"), which holds all of the outstanding shares of Common Stock of the Issuer (100,000 shares of Common Stock). The members of the Company have pass through voting rights with respect to any action proposed at a meeting Page 3 of 7 pages of the shareholders of the Issuer or submitted for consent of the shareholders of the Issuer. As a result, the reporting person may be deemed to beneficially own 10,000 shares (or 10%) of the outstanding shares of Common Stock of the Issuer. (b) Percent of class: As a result of its membership interest in the Company, the reporting person may be deemed to beneficially own 10% of the outstanding shares of Common Stock of the Issuer. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 10,000 shares of Common Stock (see (a) and (b) above). (ii) Shared power to vote or to direct the vote: 0. (iii) Sole power to dispose or to direct the disposition of: 10,000 shares of Common Stock (see (a) and (b) above). (iv) Shared power to dispose or to direct the disposition of: 0. Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Page 4 of 7 pages Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Venture Lending & Leasing IV, Inc. and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 16, 2005 PFIZER MASTER TRUST By: /s/ Sharon Kinsman -------------------------------- Name: Sharon Kinsman Its: Assistant Treasurer Page 5 of 7 pages Exhibit Index 24.1 Power of Attorney, dated February 16, 2005. Page 6 of 7 pages EX-24 2 p19235-ex24_1.txt EXHIBIT 24.1 Exhibit 24.1 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned hereby constitutes and appoints Brian R. Best, Douglas D. Reed and Bruce Levin, and each of them, any of whom may act without joinder of the others, its true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for it and in its name, place, and stead, in any and all capacities, to sign and file one or more of Schedules 13G, and amendments thereto, reporting on the undersigned's beneficial ownership of securities of Venture Lending & Leasing IV, Inc. ("Fund IV"), pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, granting unto such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as it might or could do, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or the substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Schedule 13G with respect to the undersigned's holdings of and transactions in securities issued by Fund IV, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. Dated: February 16, 2005 PFIZER MASTER TRUST By: /s/ Sharon Kinsman -------------------------------- Name: Sharon Kinsman Its: Assistant Treasurer Page 7 of 7 pages